SOPHiA GENETICS (SOPH) Registration Filing summary

Company overview and business model

• Operates as a cloud-native software technology company in healthcare, focusing on data-driven medicine and life sciences research.

• Built a platform to analyze and generate insights from complex multimodal data sets and diagnostic modalities.

• Incorporated in Switzerland since 2011, with principal offices in Rolle, Switzerland, and a U.S. presence in Boston.

Financial performance and metrics

• Financial statements are prepared in accordance with IFRS Accounting Standards and presented in U.S. dollars.

• No U.S. GAAP financials; all references to currency are in USD or CHF as indicated.

Use of proceeds and capital allocation

• Will not receive any proceeds from the sale of ordinary shares by the selling shareholder.

• Selling shareholder is responsible for brokerage commissions; company covers registration and related expenses.